bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.1691
-0.0135 (-7.39%)
At close: Sep 18, 2025, 4:00 PM EDT
0.1696
+0.0005 (0.30%)
After-hours: Sep 18, 2025, 5:22 PM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $4.77 million as of September 18, 2025. Its market cap has decreased by -76.45% in one year.
Market Cap
4.77M
Enterprise Value
5.01M
1-Year Change
-76.45%
Ranking
Category
Stock Price
$0.17
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $4.77M, a decrease of -89.42%. That is a compound annual growth rate of -52.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 5.15M | -63.71% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
| Sep 1, 2022 | 45.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |